Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > LILRB1

LILRB1

Brief Information

Name:Leukocyte immunoglobulin-like receptor B1
Target Synonym:Leukocyte Immunoglobulin Like Receptor B1,LIR-1,MIR-7,ILT2,LIR1,Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 1 Soluble Isoform,PIR-B,Leukocyte immunoglobulin-like receptor 1,MIR7,PIRB,CD85j,Immunoglobulin-like transcript 2,Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 1,Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 1,Monocyte/Macrophage Immunoglobulin-Like Receptor 7,CD85 Antigen-Like Family Member J,Myeloid Inhibitory Receptor 7,
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CDJ-H82F9 Human Biotinylated Human LILRB1 / CD85j / ILT2 Protein, Fc,Avitag™ (MALS verified)
CDJ-H82F9-structure
CDJ-H82F9-sds
CDJ-H52H6 Human Human LILRB1 / CD85j / ILT2 (23-431) Protein, His Tag (MALS verified)
CDJ-H52H6-structure
CDJ-H52H6-sds
CDJ-H82E8 Human Biotinylated Human LILRB1 / CD85j / ILT2 Protein, His,Avitag™ (MALS verified)
CDJ-H82E8-structure
CDJ-H82E8-sds
CDJ-H52H4 Human Human LILRB1 / CD85j / ILT2 Protein, His Tag (MALS verified)
CDJ-H52H4-structure
CDJ-H52H4-sds
CDJ-C52H3 Cynomolgus Cynomolgus LILRB1 / CD85j / ILT2 Protein, His Tag
CDJ-C52H3-structure
CDJ-C52H3-sds
CDJ-H82F7 Human Biotinylated Human LILRB1 / CD85j / ILT2 Protein, Fc,Avitag™
CDJ-H82F7-structure
CDJ-H82F7-sds
CDJ-H5252 Human Human LILRB1 / CD85j / ILT2 Protein, Fc Tag (MALS verified)
CDJ-H5252-structure
CDJ-H5252-sds
ACRO Quality

Part of Bioactivity data

CDJ-H52H6-SPR
LILRB1 SPR

Biotinylated Human HLA-G&B2M&Peptide (RIIPRHLQL) Complex Protein (Cat. No. HLM-H82E4) captured on Biotin CAP-Series S Sensor Chip can bind Human LILRB1 (23-431) Protein, His Tag (Cat. No. CDJ-H52H6) with an affinity constant of 6.31 μM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Protocol
CDJ-H52H4-SPR
LILRB1 SPR

Biotinylated Human HLA-G&B2M&Peptide (RIIPRHLQL) Complex Protein (Cat. No. HLM-H82E4) captured on Biotin CAP-Series S Sensor Chip can bind Human LILRB1, His Tag (Cat. No. CDJ-H52H4) with an affinity constant of 10.8 μM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Protocol

Customer Reviews

Synonym Name

CD85J,LILRB1,CD85,ILT2,LIR1,MIR7

Background

CD85 antigen-like family member J (CD85J) is also known as Leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1 or LIR-1), Immunoglobulin-like transcript 2 (ILT-2), Monocyte/macrophage immunoglobulin-like receptor 7 (MIR7), which belongs to leukocyte immunoglobulin-like receptor (LIR) family. CD85J / LILRB1 Contains 4 Ig-like C2-type (immunoglobulin-like) domains. CD85J / LIR-1 is expressed predominantly on B-cells and monocytes.  CD85J is receptor for class I MHC antigens and recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles and is also receptor for H301/UL18, a human cytomegalovirus class I MHC homolog. Ligand binding results in inhibitory signals and down-regulation of the immune response. CD85J / LILRB1 interaction with HLA-B or HLA-E leads to inhibition of the signal triggered by FCER1A and inhibits serotonin release. CD85J / LILRB1 inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
NGM-707 NGM-707 Phase 2 Clinical Merck & Co, Ngm Biopharmaceuticals Inc Ovarian Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Glioblastoma; Mesothelioma; Cholangiocarcinoma; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma Details
BND-22 BND-22; SAR-444881 Phase 2 Clinical Biond Biologics Ltd, Sanofi Neoplasms Details
IOS-1002 ios-H2 Phase 1 Clinical ImmunOs Therapeutics AG Solid tumours; Hematologic Neoplasms Details
AGEN-1571 AGEN-1571 Phase 1 Clinical Agenus Inc Solid tumours; Neoplasms Details
NGM-707 NGM-707 Phase 2 Clinical Merck & Co, Ngm Biopharmaceuticals Inc Ovarian Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Glioblastoma; Mesothelioma; Cholangiocarcinoma; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma Details
BND-22 BND-22; SAR-444881 Phase 2 Clinical Biond Biologics Ltd, Sanofi Neoplasms Details
IOS-1002 ios-H2 Phase 1 Clinical ImmunOs Therapeutics AG Solid tumours; Hematologic Neoplasms Details
AGEN-1571 AGEN-1571 Phase 1 Clinical Agenus Inc Solid tumours; Neoplasms Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap